The Food and Drug Administration (FDA) inspected Big Gain in Plato on April 22 to evaluate its handling of marketed animal drugs, feed, and devices, according to data posted on the FDA’s website.
The inspection report recommended that Big Gain voluntarily address issues related to the management of its operations.
The FDA regularly inspects facilities across the United States to verify that workplaces and their products comply with FDA regulations intended to protect public health. The results of these inspections are made public.
According to its website, the FDA is a federal agency responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
